Alcidion (ASX:ALC) renews ACT Health contract

Company News

by Katrina Bullock

Biotech company Alcidion Group (ASX:ALC) has renewed its ongoing support services contract with ACT Health for an additional 2 years.

The contract extension is valued at $1.3 million and effective from 1 January 2021.

It relates to the provision of integrated patient management system services.

Managing Director of Alcidion, Kate Quirke, says the company is “proud of [its] longstanding relationship with ACT Health and look[s] forward to providing ongoing technical support services that will support ACT Health’s ongoing commitment to providing highly integrated healthcare across all its facilities in Canberra”.

Shares in Alcidion Group (ASX:ALC) are trading 3.3 per cent higher at $0.15.